Clinical Trial Update: Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating toripalimab plus radiotherapy for elderly esophageal cancer patients managed without chemotherapy; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Taizhou Hospital | Conditions: Esophageal Cancer, Radiation Therapy | Phase 2, Phase 3 | Status: UNKNOWN